Polycystic Ovary Syndrome
Polycystic Ovary Syndrome (PCOS) is the most common endocrine disorder among women of reproductive age, characterized by high androgen levels, infertility, cysts on the ovaries, and metabolic abnormalities. While cysts may form on the ovaries, they are not a universal symptom and not the underlying cause of the disorder.
Health Outcomes
- Atherogenic Lipid Profile
- Change in Waist-to-Hip Ratio
- Changed Estrogen Level
- Changed Gonadal Hormone Level
- Changed Plasma Glycerophospholipid Levels
- Changed Testosterone Level
- Changed Vaginal Microbiota Composition
- Characterized Carbohydrate Metabolism Enzyme Activity
- Decreased HDL Cholesterol Level
- Distinct Metabolic Profile
- Elevated Hormone Levels
- Elevated Insulin Levels
- Elevated Serum Leptin Levels
- Enhanced AMPK Activation
- Enhanced Insulin Secretion
- Improved Adipocyte Inflammatory Profile
- Improved Adipokine Profile
- Improved Anthropometric Measures
- Improved Body Mass Index
- Improved Clinical Pregnancy
- Improved Clinical Pregnancy Rate
- Improved Cycle Regularity
- Improved Embryo Quality
- Improved Endocrine Function
- Improved Fertility
- Improved Fertility Rate
- Improved Fertilization Rate
- Improved Glucose Homeostasis
- Improved HOMA Index
- Improved Hormonal Profile
- Improved Hormone Secretion
- Improved Incretin Release
- Improved Insulin Levels
- Improved Insulin Resistance
- Improved Insulin Response
- Improved Insulin Secretion Rate
- Improved Insulin Sensitivity
- Improved Laying Performance
- Improved Live Birth Rate
- Improved Maternal Metabolic Health
- Improved Metabolic Function
- Improved Metabolic Health
- Improved Metabolic Homeostasis
- Improved Obesity Metrics
- Improved Obesity Parameters
- Improved Oocyte Maturity Rate
- Improved Oocyte Recovery
- Improved Ovulation
- Improved Prognosis of Type 2 Diabetes Mellitus
- Improved Protein Secretion
- Improved Reproductive Health
- Improved Reproductive Health Parameters
- Improved Satiety Hormonal Status
- Improved Satiety Index
- Improved Sex Hormone Balance
- Improved Steroidogenesis
- Improved Total Hair Density
- Improved Weight Loss
- Increased Adipogenesis
- Increased Adipose Browning
- Increased Appendicular Lean Mass
- Increased Blood Glucose Levels
- Increased Body Mass
- Increased Body Mass Index
- Increased Body Weight
- Increased Body Weight Gain
- Increased Branched Chain Amino Acid Levels
- Increased Caloric Intake in Females
- Increased Chemical Pregnancy Rate
- Increased Daily Weight Gain
- Increased Dominant Follicle Count
- Increased Embryo Number
- Increased Endometrial Thickness
- Increased Estradiol Level
- Increased Fasting Insulin Level
- Increased Femoral Neck Bone Mineral Density
- Increased Free Testosterone Level
- Increased GLP-1 Levels
- Increased Glucagon-Like Peptide 1 Level
- Increased Hair Count
- Increased Hair Density
- Increased Insulin Level
- Increased Insulin Resistance Level
- Increased Insulin Response
- Increased Insulin Secretion
- Increased LH Level
- Increased Leptin Level
- Increased Leptin Levels
- Increased Milk Production
- Increased Number of Pregnancies
- Increased Other Serum Hormone Level
- Increased Preovulatory Follicle Count
- Increased Progesterone Level
- Increased Propionate Production
- Increased Serum Insulin Levels
- Increased Serum Testosterone Level
- Increased Serum Testosterone Levels
- Increased Serum Triglycerides
- Increased Skeletal Muscle Index
- Increased Skeletal Muscle Mass
- Increased Skin Sebum Production
- Increased Testosterone Level
- Increased Testosterone Production
- Increased Total Testosterone
- Increased Total Testosterone Level
- Increased Vaginal Maturation Index
- Increased Weight
- Increased Weight Gain Post-Challenge
- Increased Weight Gain Rate
- Maintained Female Reproductive Tract Homeostasis
- No Change in Body Weight or Cardiometabolic Parameters
- No Change in Body Weight or Food Consumption
- No Change in FSH Level
- No Change in Metabolic Health
- No Change in Overall Glucose Response
- No Change in Serum Triglycerides
- No Significant Change in Androgen Levels
- Prevention of Weight Gain
- Promoted Weight Gain
- Reduced Abdominal Fat
- Reduced Abnormal Eggs
- Reduced Adipocyte Hypertrophy
- Reduced Adipocyte Senescence
- Reduced Adiposity
- Reduced Adipsin Level
- Reduced Blood Glucose Levels
- Reduced Diabetes Incidence
- Reduced Diabetes Risk
- Reduced Fasting Insulin Level
- Reduced Fat Gain
- Reduced Fetal Loss
- Reduced Free Androgen Index
- Reduced GLP-1 Levels
- Reduced HDL Cholesterol Level
- Reduced HOMA-IR
- Reduced Hair Shaft Diversity
- Reduced Homeostatic Model Assessment for Insulin Resistance
- Reduced Inflammation in the Female Reproductive Tract
- Reduced Insulin Requirement
- Reduced Insulin Response
- Reduced Insulin Sensitivity
- Reduced Lysophosphatidylethanolamine 18:1 Level
- Reduced Menstrual Bleeding
- Reduced Mesenteric Adipose Tissue Accumulation
- Reduced Metabolic Disease Risk
- Reduced Metabolic Dysregulation
- Reduced Metabolic Function
- Reduced Miscarriage
- Reduced Number of Broken Eggs
- Reduced Number of Downgraded Eggs
- Reduced Obesity-Related Taxa
- Reduced Oxidative Stress Index
- Reduced Postprandial Glycemic Response
- Reduced Postprandial Insulin
- Reduced Postprandial Insulin Response
- Reduced Recombinant Human Follicle-Stimulating Hormone Dosage
- Reduced Recurrent Implantation Failure
- Reduced Resistance Index
- Reduced TMAO Levels
- Reduced Type 2 Diabetes Symptoms
- Reduced Uterine Inflammatory Factors
- Reduced Visfatin Level
- Reduced Waist Circumference
- Reduced Waist-to-Height Ratio
- Regulated Hormone Level
- Stable Androgen Levels
- Unchanged Insulin Resistance
- Unchanged Offspring Number
- Weight Gain Consistency